Literature DB >> 11021896

Predictors of an antibiotic prescription by GPs for respiratory tract infections: a pilot.

S Murray1, C Del Mar, P O'Rourke.   

Abstract

BACKGROUND: Antibiotics are over-prescribed for respiratory tract infections in Australia.
OBJECTIVES: The aim of this study was to describe the clinical predictors of GPs' prescribing of antibiotics.
METHODS: We used Clinical Judgment Analysis to study the responses of GPs to hypothetical paper-based vignettes of a 20-year-old with a respiratory tract infection. The nature of four symptoms and signs (colour of nasal mucous discharge; soreness of the throat; presence of fever; and whether any cough was productive of sputum) was varied and their effect on prescribing measured using logistic regression.
RESULTS: Twenty GPs participated. The nature of each symptom and sign significantly predicted prescribing of an antibiotic. Cough productive of yellow sputum; presence of sore throat; fever; and coloured nasal mucus increased the probability of an antibiotic being prescribed.
CONCLUSIONS: GPs are influenced by clinical signs and symptoms to use antibiotics for respiratory infections for which there is poor evidence of efficacy from the literature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11021896     DOI: 10.1093/fampra/17.5.386

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  17 in total

1.  GPs should reduce antibiotic use with alternative treatments.

Authors:  Michael Nissen; Chris Del Mar
Journal:  BMJ       Date:  2002-05-04

2.  Diagnosing coughs and colds.

Authors:  Jenny Doust; Chris Del Mar
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

3.  Is dyspraxia a medical condition or a social disorder?

Authors:  Amanda Kirby
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

4.  Reducing inappropriate antibiotic prescribing for children in primary care: a cluster randomised controlled trial of two interventions.

Authors:  Marieke B Lemiengre; Jan Y Verbakel; Roos Colman; Tine De Burghgraeve; Frank Buntinx; Bert Aertgeerts; Frans De Baets; An De Sutter
Journal:  Br J Gen Pract       Date:  2018-02-12       Impact factor: 5.386

Review 5.  Interventions to improve antibiotic prescribing practices in ambulatory care.

Authors:  S R Arnold; S E Straus
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  How do community practitioners decide whether to prescribe antibiotics for acute respiratory tract infections?

Authors:  Robert S Wigton; Carol A Darr; Kitty K Corbett; Devin R Nickol; Ralph Gonzales
Journal:  J Gen Intern Med       Date:  2008-07-12       Impact factor: 5.128

7.  Predictors of inappropriate antibiotic prescribing among primary care physicians.

Authors:  Genevieve Cadieux; Robyn Tamblyn; Dale Dauphinee; Michael Libman
Journal:  CMAJ       Date:  2007-10-09       Impact factor: 8.262

8.  Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain.

Authors:  Juan M Vazquez-Lago; Paula Lopez-Vazquez; Ana López-Durán; Margarita Taracido-Trunk; Adolfo Figueiras
Journal:  Fam Pract       Date:  2011-10-19       Impact factor: 2.267

9.  Optimizing antibiotic prescribing for acutely ill children in primary care (ERNIE2 study protocol, part B): a cluster randomized, factorial controlled trial evaluating the effect of a point-of-care C-reactive protein test and a brief intervention combined with written safety net advice.

Authors:  Marieke B Lemiengre; Jan Y Verbakel; Tine De Burghgraeve; Bert Aertgeerts; Frans De Baets; Frank Buntinx; An De Sutter
Journal:  BMC Pediatr       Date:  2014-10-02       Impact factor: 2.125

10.  Diagnostic labelling as determinant of antibiotic prescribing for acute respiratory tract episodes in general practice.

Authors:  Huug J van Duijn; Marijke M Kuyvenhoven; Hanneke M Tiebosch; François G Schellevis; Theo J M Verheij
Journal:  BMC Fam Pract       Date:  2007-09-20       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.